Author:
Inkman Matthew J.,Jayachandran Kay,Ellis Thomas M.,Ruiz Fiona,McLellan Michael D.,Miller Christopher A.,Wu Yufeng,Ojesina Akinyemi I.,Schwarz Julie K.,Zhang Jin
Abstract
AbstractAccurate HPV genotyping is crucial in facilitating epidemiology studies, vaccine trials, and HPV-related cancer research. Contemporary HPV genotyping assays only detect < 25% of all known HPV genotypes and are not accurate for low-risk or mixed HPV genotypes. Current genomic HPV genotyping algorithms use a simple read-alignment and filtering strategy that has difficulty handling repeats and homology sequences. Therefore, we have developed an optimized expectation–maximization algorithm, designated HPV-EM, to address the ambiguities caused by repetitive sequencing reads. HPV-EM achieved 97–100% accuracy when benchmarked using cell line data and TCGA cervical cancer data. We also validated HPV-EM using DNA tiling data on an institutional cervical cancer cohort (96.5% accuracy). Using HPV-EM, we demonstrated HPV genotypic differences in recurrence and patient outcomes in cervical and head and neck cancers.
Funder
National Science Foundation
V Foundation for Cancer Research
National Institutes of Health
Publisher
Springer Science and Business Media LLC